INNV - Innovus Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue4,818.603735.7171,030.113
Cost of Revenue1,083.094340.713292.08
Gross Profit3,735.509395.004738.033
Operating Expenses
Research Development77.80477.804143.914
Selling General and Administrative9,491.6173,910.1924,378.749
Non Recurring-759.428759.428
Others---
Total Operating Expenses---
Operating Income or Loss-5,833.912-4,274.616-3,784.63
Income from Continuing Operations
Total Other Income/Expenses Net-1,203.148468.336-510.107
Earnings Before Interest and Taxes-7,037.06-3,806.28-4,294.737
Interest Expense6,661.6941,153.376532.23
Income Before Tax-13,698.754-4,959.656-4,826.967
Income Tax Expense2.4-757.028-
Minority Interest---
Net Income From Continuing Ops-13,701.154-4,235.128-5,233.8
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,701.154-4,202.628-4,826.967
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,701.154-4,202.628-4,826.967